Neuroprotective strategies following intraparenchymal hemorrhage

被引：21

作者：

Babadjouni, Robin Moshe ^{[1
]}

Radwanski, Ryan E. ^{[1
]}

Walcott, Brian P. ^{[2
]}

Patel, Arati ^{[1
]}

Durazo, Ramon ^{[1
]}

Hodis, Drew M. ^{[1
]}

Emanuel, Benjamin A. ^{[2
]}

Mack, William J. ^{[1
]}

机构：

[1] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90007 USA

[2] Univ Southern Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA USA

来源：

JOURNAL OF NEUROINTERVENTIONAL SURGERY | 2017年 / 9卷 / 12期

关键词：

SPONTANEOUS INTRACEREBRAL HEMORRHAGE; MINIMALLY INVASIVE SURGERY; ACTIVATED FACTOR-VII; BLOOD-BRAIN-BARRIER; TRANEXAMIC ACID; STATIN USE; ANTIFIBRINOLYTIC AGENT; PLATELET ACTIVITY; CONTROLLED-TRIAL; STROKE;

D O I：

10.1136/neurintsurg-2017-013197

中图分类号：

R445 [影像诊断学];

学科分类号：

100207 ;

摘要：

Intracerebral hemorrhage and, more specifically, intraparenchymal hemorrhage, are devastating disease processes with poor clinical outcomes. Primary injury to the brain results from initial hematoma expansion while secondary hemorrhagic injury occurs from blood-derived products such as hemoglobin, heme, iron, and coagulation factors that overwhelm the brains natural defenses. Novel neuroprotective treatments have emerged that target primary and secondary mechanisms of injury. Nonetheless, translational application of neuroprotectants from preclinical to clinical studies has yet to show beneficial clinical outcomes. This review summarizes therapeutic agents and neuroprotectants in ongoing clinical trials aimed at targeting primary and secondary mechanisms of injury after intraparenchymal hemorrhage.

引用

页码：1202 / +

页数：7

共 91 条

[11]

Balduini CL, 1999, HAEMATOLOGICA, V84, P891

[12] High stroke incidence in the prospective community-based L'Aquila Registry (1994-1998) - First year's results [J].

Carolei, A ;

Marini, C ;

DiNapoli, M ;

DiGianfilippo, G ;

Santalucia, P ;

Baldassarre, M ;

DeMatteis, G ;

diOrio, F .

STROKE, 1997, 28 (12) :2500-2506

[13] Early statin therapy in patients with acute intracerebral hemorrhage without prior statin use [J].

Chen, P. -S. ;

Cheng, C. -L. ;

Chang, Y. -C. ;

Yang, Y. -H. Kao ;

Yeh, P. -S. ;

Li, Y. -H. .

EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 (05) :773-780

[14] Minocycline attenuates iron neurotoxicity in cortical cell cultures [J].

Chen-Roetling, Jing ;

Chen, Lifen ;

Regan, Raymond F. .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 386 (02) :322-326

[15] Celecoxib induces functional recovery after intracerebral hemorrhage with reduction of brain edema and perihematomal cell death [J].

Chu, K ;

Jeong, SW ;

Jung, KH ;

Han, SY ;

Lee, ST ;

Kim, M ;

Roh, JK .

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2004, 24 (08) :926-933

[16] Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage [J].

Davis, SM ;

Broderick, J ;

Hennerici, M ;

Brun, NC ;

Diringer, MN ;

Mayer, SA ;

Begtrup, K ;

Steiner, T .

NEUROLOGY, 2006, 66 (08) :1175-1181

[17] RESPONSE OF PATIENTS WITH MILD AND MODERATE HEMOPHILIA-A AND VONWILLEBRANDS DISEASE TO TREATMENT WITH DESMOPRESSIN [J].

DELAFUENTE, B ;

KASPER, CK ;

RICKLES, FR ;

HOYER, LW .

ANNALS OF INTERNAL MEDICINE, 1985, 103 (01) :6-14

[18]

Dowlatshahi D, 2012, STROKEAHA, V111

[19] The Acute Management of Intracerebral Hemorrhage: A Clinical Review [J].

Elliott, Justine ;

Smith, Martin .

ANESTHESIA AND ANALGESIA, 2010, 110 (05) :1419-1427

[20] Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century [J].

Feigin, VL ;

Lawes, CMM ;

Bennett, DA ;

Anderson, CS .

LANCET NEUROLOGY, 2003, 2 (01) :43-53

← 1 2 3 4 5 6 7 8 9 10 →